FDA Drug Recalls

Recalls / Class II

Class IID-0924-2018

Product

Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, packaged in a 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat. India, NDC 62756-142-02

Brand name
Metformin Hydrochloride
Generic name
Metformin Hydrochloride
Active ingredient
Metformin Hydrochloride
Route
Oral
NDCs
62756-142, 62756-143
FDA application
ANDA077336
Affected lot / code info
Lot #: JKT0042A, Exp 1/2021

Why it was recalled

Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.

Recalling firm

Firm
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
270 Prospect Plains Rd, Cranbury, New Jersey 08512-3605

Distribution

Quantity
2508 bottles
Distribution pattern
AZ

Timeline

Recall initiated
2018-07-03
FDA classified
2018-07-13
Posted by FDA
2018-07-25
Terminated
2019-11-05
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0924-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Metformin Hydrochloride · FDA Drug Recalls